Article
Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
The Prostate - 1 May 2013
Penney Kathryn L, Li Haojie, Mucci Lorelei A, Loda Massimo, Sesso Howard D, Stampfer Meir J, Ma Jing
Abstract excerpt
BACKGROUND: Low levels of selenium have been associated with increased risk of prostate cancer (PCa). Selenoprotein P is the most abundant selenoprotein in serum and delivers ten selenocysteine residues to tissues. Variation in the selenoprotein P gene (SEPP1) may influence PCa development or modify the effects of selenium. We examined the association of SEPP1 single nucleotide polymorphisms (SNPs) with PCa risk...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
